NCT01823159View on ClinicalTrials.gov

Cortical Excitability Changes Induced by Retigabine: a Transcranial Magnetic Stimulation Study

PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2014

Conditions
Epilepsy
Interventions
DRUG

retigabine

Single oral administration of a 400 mg tablet.

DRUG

placebo

Single oral administration of a tablet

Trial Locations (1)

5350

CHU Mont-Godinne, Yvoir

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Université Catholique de Louvain

OTHER

lead

University Hospital of Mont-Godinne

OTHER